ERcast: Clinical Perspectives Podcast Preview

Subscription Required

Lit Matters 1: Which Virus Does the Child in Front of Me Have, and Does it Matter?

Cameron Berg, MD and Drew Kalnow, DO

Sign in or Subscribe to listen.
5 starson Spotify
Sign in or Subscribe to view.Sign in or Subscribe to view.

The summary below is from an episode of ERcast: Clinical Perspectives

Broad respiratory viral PCR testing rarely changes emergency department management for uncomplicated pediatric fever, cough, bronchiolitis, or viral URI. In this pediatric ED study, comprehensive respiratory viral panels were linked to higher charges, longer length of stay, and no meaningful improvement in outcomes.

Pediatric Respiratory Viral Panel Testing

  • Limited management impact: Comprehensive respiratory viral panels did not move care for typical pediatric URI presentations; bedside severity assessment mattered more than identifying rhinovirus, RSV, or another named virus.
  • Higher patient charges: CRVP testing was associated with a major jump in total charges, about $643 versus $295, without any cost advantage when the panel came back positive.
  • Longer emergency stay: Testing roughly doubled ED length of stay, from about 2 hours to 4 hours, a throughput penalty that matters during winter surge. We get into the operational implications in the episode.
  • No antibiotic reassurance: Antimicrobial use was actually higher in the tested group regardless of whether the panel was positive, undercutting the idea that more viral data automatically reduces unnecessary treatment.
  • Best use-case framing: For the child who looks like an uncomplicated viral illness, the useful split is sick versus not sick, not which virus is on the swab; the exceptions are worth hearing in the chapter.

Subscribe to ERcast: Clinical Perspectives to listen to the episode.

Faculty